Donna Capozzi

580 total citations
10 papers, 430 citations indexed

About

Donna Capozzi is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Hematology. According to data from OpenAlex, Donna Capozzi has authored 10 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Geriatrics and Gerontology and 3 papers in Hematology. Recurrent topics in Donna Capozzi's work include Pharmaceutical Practices and Patient Outcomes (3 papers), Pharmaceutical studies and practices (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Donna Capozzi is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (3 papers), Pharmaceutical studies and practices (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Donna Capozzi collaborates with scholars based in United States and Italy. Donna Capozzi's co-authors include Alessandra Carattoli, Marcello Meledandri, Nicola Petrosillo, Antonio Giordano, Maddalena Giannella, Mario Venditti, Alessandro Capone, A. Tarasi, A. Lappa and Milva Ballardini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Donna Capozzi

9 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Capozzi United States 5 240 127 112 90 87 10 430
Patrick M. McDaneld United States 9 186 0.8× 179 1.4× 24 0.2× 106 1.2× 123 1.4× 17 353
Piera Polidori Italy 10 77 0.3× 59 0.5× 74 0.7× 69 0.8× 44 0.5× 38 370
Brent W. Gunderson United States 12 167 0.7× 185 1.5× 33 0.3× 51 0.6× 101 1.2× 15 455
José Ramón Paño Pardo Spain 9 74 0.3× 32 0.3× 81 0.7× 171 1.9× 56 0.6× 23 335
Jennifer Lo Canada 9 58 0.2× 39 0.3× 67 0.6× 164 1.8× 88 1.0× 15 344
Safa S. Almarzoky Abuhussain Saudi Arabia 12 161 0.7× 133 1.0× 16 0.1× 101 1.1× 87 1.0× 28 312
Matthew F. Wack United States 10 78 0.3× 204 1.6× 27 0.2× 82 0.9× 197 2.3× 15 443
Angela Loo United States 10 151 0.6× 170 1.3× 31 0.3× 152 1.7× 151 1.7× 19 446
Girma Minalu Belgium 9 80 0.3× 122 1.0× 29 0.3× 295 3.3× 236 2.7× 11 570
Elizabeth Leung Canada 10 56 0.2× 52 0.4× 87 0.8× 192 2.1× 113 1.3× 22 510

Countries citing papers authored by Donna Capozzi

Since Specialization
Citations

This map shows the geographic impact of Donna Capozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Capozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Capozzi more than expected).

Fields of papers citing papers by Donna Capozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Capozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Capozzi. The network helps show where Donna Capozzi may publish in the future.

Co-authorship network of co-authors of Donna Capozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Capozzi. A scholar is included among the top collaborators of Donna Capozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Capozzi. Donna Capozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tuteja, Sony, Xingmei Wang, Donna Capozzi, et al.. (2025). Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial. JCO Precision Oncology. 9(9). e2500086–e2500086.
2.
Capozzi, Donna, et al.. (2023). Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network. Journal of Oncology Pharmacy Practice. 29(8). 1907–1914. 1 indexed citations
3.
MacArthur, Robert B., Ohad S. Bentur, Ian C. MacArthur, et al.. (2021). CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic. SHILAP Revista de lepidopterología. 5(1). e108–e108. 3 indexed citations
4.
Cohen, Adam D., Brendan M. Weiss, Dan T. Vogl, et al.. (2016). Pembrolizumab in Combination with Pomalidomide and Dexamethasone (PEMBRO/POM/DEX) for Pomalidomide Exposed Relapsed or Refractory Multiple Myeloma. Blood. 128(22). 2119–2119. 12 indexed citations
5.
Shah, Nirav N., Donna Capozzi, Suzanne McGettigan, et al.. (2016). Improving the Safety of Oral Chemotherapy at an Academic Medical Center. Journal of Oncology Practice. 12(1). e71–e76. 23 indexed citations
6.
Timlin, Colleen, Rahul Banerjee, Christina Howlett, et al.. (2016). Comparable outcomes in CLL patients treated with reduced-dose ibrutinib: Results from a multi-center study.. Journal of Clinical Oncology. 34(15_suppl). 7529–7529. 1 indexed citations
7.
Capone, Alessandro, Maddalena Giannella, D. Fortini, et al.. (2012). High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clinical Microbiology and Infection. 19(1). E23–E30. 260 indexed citations
8.
Bullock, Julie, Patrick F. Smith, Brent M. Booker, et al.. (2006). Development of a Pharmacokinetic and Bayesian Optimal Sampling Model for Individualization of Oral Busulfan in Hematopoietic Stem Cell Transplantation. Therapeutic Drug Monitoring. 28(1). 62–66. 18 indexed citations
9.
Bullock, Julie, Patrick F. Smith, Brent M. Booker, et al.. (2003). Bayesian Optimal Sampling Model (OSM) For Pharmacokinetic (PK) Individualization of Oral and Intravenous Busulfan (B) Regimens. Clinical Pharmacology & Therapeutics. 73(2). 1 indexed citations
10.
Nesbit, Todd, Kenneth M. Shermock, Mary Beth Bobek, et al.. (2001). Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. American Journal of Health-System Pharmacy. 58(9). 784–790. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick M. McDaneld Breakdown of academic impact, for papers by Piera Polidori Breakdown of academic impact, for papers by Brent W. Gunderson Breakdown of academic impact, for papers by José Ramón Paño Pardo Breakdown of academic impact, for papers by Jennifer Lo Breakdown of academic impact, for papers by Safa S. Almarzoky Abuhussain Breakdown of academic impact, for papers by Matthew F. Wack Breakdown of academic impact, for papers by Angela Loo Breakdown of academic impact, for papers by Girma Minalu Breakdown of academic impact, for papers by Elizabeth Leung
Rankless by CCL
2026